The Drug Information Association in Europe, in collaboration with the International Federation of Associations of Pharmaceutical Physicians (IFAPP), will host the Joint DIA/IFAPP Pharmaceutical Policy Forum from February 4-5, 2010 in London, UK.
This forum, which includes as part of the agenda, the 11th IFAPP European Conference, will highlight future pharmaceutical legislation and provide insight into how the European Medicines Agency and FDA working environments impact regulatory decision making. Professionals from regulatory agencies, industry, and Contract Research Organisations will present on emerging issues, including:
- European Medicines Agency Transparency Policy
- Future of Clinical Trial Legislation (Drugs and Devices)
- Intersection between Pharmaceutical/Device Industry and Healthcare
- Fraud and Misconduct
- Globalisation—Co-operation between FDA and the European Medicines Agency
- Standardisation of Investigational Site Qualification
Register for the Joint DIA/IFAPP Pharmaceutical Policy Forum.
About the Drug Information Association (DIA)
DIA is a neutral, global, professional, member-driven association of nearly 18,000 biotechnology, pharmaceutical, academic, and regulatory professionals. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies, and services to improve health and well being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China.
About the International Federation of Association of Pharmaceutical Physicians (IFAPP)
The Federation is a non-profit organisation and has existed since 1975. The aim of IFAPP is to act as an international forum for all the organisations of Pharmaceutical Physicians world-wide by dealing with matters suggested by its 30 National Member Associations, representing more than 8000 pharmaceutical professionals. IFAPP fosters the development and international recognition of Pharmaceutical Medicine as a medical specialty and the development of training and continuing education programmes in pharmaceutical medicine. It stimulates a closer relationship between the Member Associations and an improved understanding between the Associations and the medical and allied professionals, regulatory authorities and health care providers. Every two years a National Member Association organises the International Conference on Pharmaceutical Medicine (ICPM).
Contact: Katie Shearer McKinnon
DIA in Europe
+41 61 225 51 36